Related Experiment Video
Updated: Jun 27, 2026
09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Strategies for minimizing corticosteroid toxicity: a review
1Division of Pediatric Allergy and Immunology, Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Indian Journal of Pediatrics
|November 22, 2008
Summary
Glucocorticoids (GCs) are vital for pediatric inflammatory diseases but carry risks. Understanding GC side-effects and guidelines helps prevent and manage complications in children.
Area of Science:
- Pediatric Pharmacology
- Immunology
- Clinical Therapeutics
Background:
- Glucocorticoids (GCs) are widely used for pediatric inflammatory and autoimmune conditions.
- While effective, prolonged or high-dose GC use poses significant risks of adverse effects in children.
Purpose of the Study:
- To review common side-effects of glucocorticoid therapy in children.
- To elucidate the underlying pathophysiological mechanisms of these adverse effects.
- To emphasize evidence-based guidelines for preventing and managing GC complications.
Main Methods:
- Literature review focusing on pediatric glucocorticoid use.
- Analysis of reported side-effects and their mechanisms.
- Synthesis of clinical usage guidelines for risk mitigation.
Main Results:
- Common GC side-effects in children include growth retardation, metabolic disturbances, and immunosuppression.
- Pathophysiological mechanisms involve disruption of hormonal balance and immune function.
- Evidence-based guidelines can significantly reduce the incidence and severity of complications.
Conclusions:
- A thorough understanding of GC pharmacology and adverse reactions is crucial for safe pediatric use.
- Timely implementation of evidence-based guidelines can prevent, minimize, and treat common GC-related complications.
- Optimizing GC therapy improves patient outcomes in pediatric inflammatory and autoimmune diseases.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...